(CAH) Cardinal Health Incorporated – Bull of the Day

We upgrade our rating on Cardinal Health, Inc. (CAH) to Outperform. Earnings for the fourth quarter narrowly beat the Zacks Consensus Estimate. Cardinal’s size and diversity partly insulate it from economic cycles. Its generics business continues to grow at a healthy pace.

Moreover, Cardinal’s Pharmaceutical and Medical segments have revamped operations. The company continues to nurture its specialty platforms and engage in periodic tuck-in acquisitions. Although client and supplier concentration and reliance on group purchasing organizations remain areas of concern, the same is partly mitigated through long-term contracts.

While margins are thin in the bulk Pharma business, the business mix is evolving in favor of the non-bulk segment. Robust cash flow, high cash balance and revolving credit facility bestow liquidity for share repurchase and acquisitions.

CARDINAL HEALTH (CAH): Free Stock Analysis Report

Zacks Investment Research

About vitalstocks

This is a sample profile field. Vitalstocks is the operating company for Stockbloghub. This will place the picture of the author or company in the profile. Here is another extra line of information.


Powered by Facebook Comments

Similar Posts: | | Drugs Wholesale | Services

RSS feeds: CAH | Cardinal Health Inc. | Drugs Wholesale | Services |

Other Posts by | RSS Feed for this author